Gout clinical trials at UCSF
1 research study open to new patients

  • Gout: Allopurinol vs. Febuxostat

    open to eligible people ages 18 years and up

    This trial will compare two effective therapies, allopurinol and febuxostat, to lower serum uric acid and therefore prevent further gout attacks. These therapies have never been compared at appropriate doses. Further, they will be studied in patients with kidney disease for the first time.

    San Francisco, California and other locations

Last updated: